See more : Heera Ispat Limited (HEERAISP.BO) Income Statement Analysis – Financial Results
Complete financial analysis of National Health Investors, Inc. (NHI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of National Health Investors, Inc., a leading company in the REIT – Healthcare Facilities industry within the Real Estate sector.
You may be interested
- Guangdong Wanlima Industry Co. ,Ltd (300591.SZ) Income Statement Analysis – Financial Results
- Heungkuk Fire&Marine Insurance Co., Ltd. (000545.KS) Income Statement Analysis – Financial Results
- Premium Water Holdings,Inc. (2588.T) Income Statement Analysis – Financial Results
- G-H-3 International Inc. (GHTI) Income Statement Analysis – Financial Results
- IndoStar Capital Finance Limited (INDOSTAR.NS) Income Statement Analysis – Financial Results
National Health Investors, Inc. (NHI)
About National Health Investors, Inc.
Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 319.84M | 278.19M | 298.72M | 332.81M | 318.08M | 294.61M | 278.66M | 248.50M | 228.99M | 177.51M | 117.83M | 96.95M | 82.70M | 78.40M | 64.22M | 63.01M | 62.31M | 150.72M | 157.38M | 155.56M | 162.49M | 171.78M | 139.17M | 147.51M | 131.16M | 102.29M | 110.18M | 99.43M | 87.90M | 71.40M | 49.50M | 39.40M | 7.90M |
| Cost of Revenue | 11.51M | 9.79M | 11.64M | 9.65M | 5.80M | 1.17M | 960.00K | 1.01M | 985.00K | 620.00K | 616.00K | 771.00K | 0.00 | 2.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 308.32M | 268.41M | 287.08M | 323.16M | 312.28M | 293.45M | 277.70M | 247.49M | 228.00M | 176.89M | 117.21M | 96.18M | 82.70M | 76.39M | 64.22M | 63.01M | 62.31M | 150.72M | 157.38M | 155.56M | 162.49M | 171.78M | 139.17M | 147.51M | 131.16M | 102.29M | 110.18M | 99.43M | 87.90M | 71.40M | 49.50M | 39.40M | 7.90M |
| Gross Profit Ratio | 96.40% | 96.48% | 96.10% | 97.10% | 98.18% | 99.60% | 99.66% | 99.59% | 99.57% | 99.65% | 99.48% | 99.20% | 100.00% | 97.44% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Research & Development | 0.00 | 0.23 | 0.38 | 0.57 | 0.50 | 0.52 | 0.58 | 0.65 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 19.72M | 25.32M | 19.34M | 14.56M | 13.91M | 12.86M | 12.71M | 10.20M | 10.98M | 9.32M | 10.04M | 8.57M | 8.03M | 8.85M | 7.21M | 5.18M | 5.66M | 5.34M | 4.31M | 3.49M | 3.14M | 2.43M | 3.30M | 3.46M | 3.28M | 3.89M | 3.70M | 3.69M | 3.40M | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 100.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 19.82M | 25.32M | 19.34M | 14.56M | 13.91M | 12.86M | 12.71M | 10.20M | 10.98M | 9.32M | 10.04M | 8.57M | 8.03M | 8.85M | 7.21M | 5.18M | 5.66M | 5.34M | 4.31M | 3.49M | 3.14M | 2.43M | 3.30M | 3.46M | 3.28M | 3.89M | 3.70M | 3.69M | 3.40M | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 109.71M | 99.92M | 134.35M | 84.68M | 78.37M | 71.35M | 67.17M | 1.66M | 53.16M | 38.08M | 3.31M | 4.85M | 12.81M | 11.05M | 7.37M | 8.55M | 2.36M | 95.15M | 116.67M | 96.24M | 101.89M | 127.25M | 115.83M | 81.79M | 99.86M | 47.87M | 53.31M | 49.21M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 129.53M | 125.24M | 153.69M | 99.23M | 92.27M | 85.37M | 80.84M | 70.77M | 65.13M | 48.01M | 30.76M | 25.92M | 20.84M | 19.90M | 14.58M | 13.73M | 8.01M | 100.50M | 120.98M | 99.73M | 105.03M | 129.67M | 119.13M | 85.25M | 103.14M | 51.76M | 57.01M | 52.90M | -7.60M | -10.50M | -8.20M | -7.10M | -1.60M |
| Cost & Expenses | 143.36M | 135.03M | 165.33M | 108.88M | 98.07M | 85.37M | 80.84M | 70.77M | 65.13M | 48.01M | 30.76M | 25.92M | 20.84M | 19.90M | 14.58M | 13.73M | 8.01M | 100.50M | 120.98M | 99.73M | 105.03M | 129.67M | 119.13M | 85.25M | 103.14M | 51.76M | 57.01M | 52.90M | -7.60M | -10.50M | -8.20M | -7.10M | -1.60M |
| Interest Income | -2.65M | 44.92M | 50.81M | 52.88M | 56.30M | 0.00 | 18.00K | 0.00 | 0.00 | 0.00 | 6.74M | 1.24M | 6.49M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Interest Expense | 55.51M | 44.92M | 50.81M | 52.88M | 56.30M | 49.06M | 43.11M | 9.23M | 3.49M | 3.85M | 1.55M | 85.00K | 308.00K | 4.63M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Depreciation & Amortization | 69.97M | 140.03M | 165.45M | 106.65M | 99.16M | 89.79M | 79.96M | 86.12M | 53.16M | 40.69M | 20.10M | 16.58M | 11.99M | 10.99M | 8.62M | 7.94M | 11.73M | 11.81M | 12.60M | 14.45M | 15.38M | 16.38M | 14.66M | 14.17M | 11.49M | 8.96M | 8.04M | 6.83M | 6.10M | 5.30M | 5.20M | 4.70M | 1.20M |
| EBITDA | 251.49M | 151.99M | 212.99M | 303.95M | 296.83M | 280.59M | 264.99M | 236.08M | 179.36M | 167.06M | 107.63M | 87.66M | 76.05M | 68.15M | 57.57M | 53.34M | 82.87M | 66.31M | 49.38M | 55.29M | 72.84M | 247.76M | 233.19M | 77.60M | 91.44M | 60.18M | 61.21M | 54.48M | 101.60M | 87.20M | 62.90M | 51.20M | 10.70M |
| EBITDA Ratio | 78.63% | 54.64% | 71.30% | 91.33% | 93.32% | 95.24% | 95.09% | 95.00% | 94.00% | 93.17% | 91.23% | 90.42% | 71.48% | 82.01% | 81.52% | 80.51% | 84.55% | 32.83% | 20.37% | 37.71% | 44.83% | 31.39% | 25.71% | 52.61% | 30.69% | 58.83% | 55.55% | 54.79% | 115.59% | 122.13% | 127.07% | 129.95% | 135.44% |
| Operating Income | 178.79M | 81.11M | 132.19M | 220.80M | 220.01M | 209.24M | 197.82M | 177.73M | 163.86M | 106.19M | 77.84M | 71.04M | 61.86M | 58.50M | 49.64M | 49.27M | 54.30M | 50.23M | 36.40M | 55.83M | 57.46M | 42.11M | 20.04M | 62.26M | 28.02M | 50.53M | 53.17M | 46.53M | 95.50M | 81.90M | 57.70M | 46.50M | 9.50M |
| Operating Income Ratio | 55.90% | 29.16% | 44.25% | 66.34% | 69.17% | 71.02% | 70.99% | 71.52% | 71.56% | 59.82% | 66.07% | 73.27% | 74.80% | 74.62% | 77.30% | 78.20% | 87.14% | 33.32% | 23.13% | 35.89% | 35.36% | 24.51% | 14.40% | 42.21% | 21.37% | 49.40% | 48.26% | 46.80% | 108.65% | 114.71% | 116.57% | 118.02% | 120.25% |
| Total Other Income/Expenses | -44.41M | -80.22M | -15.04M | -33.54M | -59.56M | -49.94M | -38.45M | -74.13M | -66.10M | -26.44M | -28.49M | 0.00 | 7.95M | -707.00K | 0.00 | 0.00 | -3.48M | 8.44M | 16.93M | -4.89M | 0.00 | -185.02M | -218.78M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax | 134.38M | 65.50M | 111.97M | 185.31M | 160.45M | 154.33M | 159.37M | 153.47M | 149.61M | 103.05M | 79.50M | 74.66M | 81.13M | 69.42M | 64.23M | 57.51M | 67.64M | 62.95M | 53.71M | 67.52M | 0.00 | 47.19M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | 42.02% | 23.55% | 37.48% | 55.68% | 50.44% | 52.39% | 57.19% | 61.76% | 65.33% | 58.05% | 67.47% | 77.01% | 98.10% | 88.55% | 100.01% | 91.28% | 108.55% | 41.76% | 34.13% | 43.41% | 0.00% | 27.47% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 42.44M | 49.78M | 49.94M | 56.29M | -9.17M | 46.32M | 749.00K | -707.00K | 24.67M | -17.13M | -12.53M | -19.27M | -10.92M | -14.59M | -8.24M | -42.13M | -18.83M | -17.65M | -472.00K | 13.66M | 11.83M | 21.19M | 29.70M | -24.85M | -18.42M | -22.22M | -19.52M | 45.80M | 43.00M | 33.30M | 33.20M | 7.40M |
| Net Income | 135.65M | 23.06M | 62.19M | 135.37M | 104.16M | 154.33M | 159.37M | 151.54M | 148.86M | 101.61M | 106.18M | 90.73M | 81.13M | 69.42M | 64.23M | 57.51M | 96.44M | 69.23M | 54.41M | 56.38M | 43.81M | 30.79M | -63.00K | 33.72M | 53.62M | 69.65M | 75.39M | 67.16M | 49.70M | 38.90M | 24.40M | 13.30M | 2.10M |
| Net Income Ratio | 42.41% | 8.29% | 20.82% | 40.67% | 32.75% | 52.39% | 57.19% | 60.98% | 65.01% | 57.24% | 90.12% | 93.58% | 98.10% | 88.55% | 100.01% | 91.28% | 154.76% | 45.93% | 34.57% | 36.24% | 26.96% | 17.92% | -0.05% | 22.86% | 40.88% | 68.08% | 68.42% | 67.55% | 56.54% | 54.48% | 49.29% | 33.76% | 26.58% |
| EPS | 3.13 | 0.52 | 1.36 | 3.03 | 2.40 | 3.68 | 3.90 | 3.88 | 3.96 | 3.04 | 3.74 | 3.26 | 2.93 | 2.51 | 2.33 | 2.08 | 3.48 | 2.50 | 1.96 | 2.05 | 1.58 | 1.10 | 0.00 | 1.31 | 2.13 | 2.72 | 3.01 | 2.92 | 2.63 | 2.35 | 1.95 | 1.60 | 0.29 |
| EPS Diluted | 3.13 | 0.51 | 1.36 | 3.03 | 2.38 | 3.67 | 3.87 | 3.87 | 3.95 | 3.04 | 3.74 | 3.26 | 2.92 | 2.50 | 2.32 | 2.07 | 3.47 | 2.49 | 1.96 | 2.03 | 1.57 | 1.10 | 0.00 | 1.31 | 2.13 | 2.69 | 2.92 | 2.80 | 2.49 | 2.28 | 1.95 | 1.60 | 0.29 |
| Weighted Avg Shares Out | 43.39M | 44.77M | 45.71M | 44.70M | 43.42M | 41.94M | 40.89M | 39.01M | 37.60M | 33.38M | 28.36M | 27.81M | 27.72M | 27.66M | 27.59M | 27.71M | 27.70M | 27.74M | 27.70M | 27.26M | 26.73M | 26.45M | 24.47M | 24.38M | 24.37M | 24.96M | 24.42M | 21.94M | 16.39M | 13.28M | 12.51M | 7.48M | 7.24M |
| Weighted Avg Shares Out (Dil) | 43.39M | 44.79M | 45.73M | 44.70M | 43.70M | 42.09M | 41.15M | 39.16M | 37.64M | 33.42M | 28.40M | 27.84M | 27.79M | 27.73M | 27.62M | 27.73M | 27.78M | 27.78M | 27.83M | 27.53M | 26.99M | 26.85M | 24.47M | 24.56M | 24.37M | 28.69M | 25.17M | 27.24M | 17.31M | 13.68M | 12.51M | 7.48M | 7.24M |
3 Blue-Chip Stocks With Strong Dividend Yields
Looking for consistent returns and steady income from your investments? Blue-chip dividend stocks may be your answer.
3 Supercharged Dividend Stocks to Buy If There's a Stock Market Sell-Off
Innovative Industrial Properties and NewLake Capital cater to the cannabis industry. National Health Investors is a real estate investment trust that focuses on senior housing.
National Health: What We Got Wrong With This Healthcare REIT
National Health REIT delivered one dividend cut on schedule but we thought there would be more. We look at what we got right and what we got wrong in our previous piece. We update the outlook for this and give...
National Health Investors, Inc. (NHI) Q1 2023 Earnings Call Transcript
National Health Investors, Inc. (NYSE:NHI ) Q1 2023 Earnings Conference Call May 10, 2023 12:00 PM ET Company Participants Dana Hambly - Director of IR Eric Mendelsohn - President and CEO John Spaid - CFO Kevin Pascoe - Chief Investment...
National Health Investors (NHI) Q1 FFO and Revenues Beat Estimates
National Health Investors (NHI) came out with quarterly funds from operations (FFO) of $1.11 per share, beating the Zacks Consensus Estimate of $0.99 per share. This compares to FFO of $1.10 per share a year ago.
NHI Announces First Quarter 2023 Earnings Release and Conference Call Date
MURFREESBORO, TN / ACCESSWIRE / April 18, 2023 / National Health Investors, Inc. (NYSE:NHI) announced details for the release of its results for the first quarter ended March 31, 2023. NHI plans to issue its earnings release after the market...
Healthcare REITs: Life After The Pandemic
For Healthcare REITs - the physical epicenter of the pandemic - the road to recovery has remained inconsistent across its distinct sub-sectors, with "private-pay" segments now showing notable improvement while "public-pay" segments relapse. Public-pay segments - Hospital and Skilled-Nursing -...
National Health Investors, Inc. (NHI) Q4 2022 Earnings Call Transcript
National Health Investors, Inc. (NYSE:NHI ) Q4 2022 Earnings Conference Call February 22, 2023 12:00 PM ET Company Participants Dana Hambly - Director of Investor Relations Eric Mendelsohn - President and Chief Executive Officer Kevin Pascoe - Chief Investment Officer...
National Health Investors (NHI) Lags Q4 FFO and Revenue Estimates
National Health Investors (NHI) delivered FFO and revenue surprises of -23.42% and 8.12%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Why I Sold National Health Investors
I originally bought NHI, in part, because it was one of the few senior housing REITs fully invested in triple-net leased properties. With the conversion of 15 properties into SHOP assets, that is no longer the case. More SHOP conversions...
Source: https://incomestatements.info
Category: Stock Reports